Literature DB >> 28110987

Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals.

Ian G Stiell1, Catherine M Clement2, Brian H Rowe3, Robert J Brison4, D George Wyse5, David Birnie6, Paul Dorian7, Eddy Lang8, Jeffrey J Perry9, Bjug Borgundvaag10, Debra Eagles9, Damian Redfearn11, Jennifer Brinkhurst2, George A Wells12.   

Abstract

STUDY
OBJECTIVE: Recent-onset atrial fibrillation and flutter are the most common arrhythmias managed in the emergency department (ED). We evaluate the management and 30-day outcomes for recent-onset atrial fibrillation and flutter patients in Canadian EDs, where cardioversion is commonly practiced.
METHODS: We conducted a prospective cohort study in 6 academic hospital EDs and enrolled patients who had atrial fibrillation and flutter onset within 48 hours. Patients were followed for 30 days by health records review and telephone. Adverse events included death, stroke, acute coronary syndrome, heart failure, subsequent admission, or ED electrocardioversion.
RESULTS: We enrolled 1,091 patients with mean age 63.9 years, atrial fibrillation 84.7%, atrial flutter 15.3%, hospital admission 9.0%, and converted to sinus rhythm 80.1%. Although 10.5% of recent-onset atrial fibrillation and flutter patients had adverse events within 30 days, there were no related deaths and 1 stroke (0.1%). Adjusted odds ratios for factors associated with adverse event were hours from onset (1.03/hour; 95% confidence interval [CI] 1.01 to 1.05), history of stroke or transient ischemic attack (2.09; 95% CI 1.01 to 4.36), and pulmonary congestion on chest radiograph (7.37; 95% CI 2.40 to 22.64). Patients who left the ED in sinus rhythm were much less likely to experience an adverse event (P<.001).
CONCLUSION: Although most recent-onset atrial fibrillation and flutter patients were treated aggressively in the ED, there were few 30-day serious outcomes. Physicians underprescribed oral anticoagulants. Potential risk factors for adverse events include longer duration from arrhythmia onset, previous stroke or transient ischemic attack, pulmonary congestion on chest radiograph, and not being in sinus rhythm at discharge. An ED strategy of sinus rhythm restoration and discharge in most patients is effective and safe.
Copyright © 2016 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28110987     DOI: 10.1016/j.annemergmed.2016.10.013

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  12 in total

1.  Does shifting to professional emergency department staffing affect the decision for chest radiography?

Authors:  Marin Pavlov; Lucija Klobučar; Iva Klobučar; Kristina Žgela; Vesna Degoricija
Journal:  World J Emerg Med       Date:  2021

2.  Understanding the effect of propofol and electrical cardioversion on the systolic blood pressure of emergency department patients with atrial fibrillation.

Authors:  David R Vinson; Bory Kea
Journal:  World J Emerg Med       Date:  2018

3.  Is delayed cardioversion the better approach in recent-onset atrial fibrillation? No.

Authors:  Alessandro Capucci; Paolo Compagnucci
Journal:  Intern Emerg Med       Date:  2019-11-13       Impact factor: 3.397

4.  Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation.

Authors:  Clare L Atzema; Cynthia A Jackevicius; Alice Chong; Paul Dorian; Noah M Ivers; Ratika Parkash; Peter C Austin
Journal:  CMAJ       Date:  2019-12-09       Impact factor: 8.262

5.  From Bench to Bedside-Implementing the New ABC Approach for Atrial Fibrillation in an Emergency Department Setting.

Authors:  Sophie Gupta; Martin Lutnik; Jan Niederdöckl; Sebastian Schnaubelt
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 4.614

6.  Predictors of time to conversion of new-onset atrial fibrillation to sinus rhythm with amiodarone therapy.

Authors:  Ihsan Dursun; Sinan Sahin; Ali Bayraktar; Omer Faruk Cirakoglu; Selim Kul; Levent Korkmaz
Journal:  J Arrhythm       Date:  2020-06-01

7.  Is delayed cardioversion the better approach in recent-onset atrial fibrillation? Yes.

Authors:  Giovanni Luca Botto; Giovanni Tortora
Journal:  Intern Emerg Med       Date:  2019-12-13       Impact factor: 3.397

8.  Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis.

Authors:  Brenton M Wong; Jeffrey J Perry; Wei Cheng; Bo Zheng; Kevin Guo; Monica Taljaard; Allan C Skanes; Ian G Stiell
Journal:  CJEM       Date:  2021-03-14       Impact factor: 2.410

9.  Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department.

Authors:  David R Vinson; E Margaret Warton; Dustin G Mark; Dustin W Ballard; Mary E Reed; Uli K Chettipally; Nimmie Singh; Sean Z Bouvet; Bory Kea; Patricia C Ramos; David S Glaser; Alan S Go
Journal:  West J Emerg Med       Date:  2018-02-12

10.  Impact of a Multidisciplinary Treatment Pathway for Atrial Fibrillation in the Emergency Department on Hospital Admissions and Length of Stay: Results of a Multi-Center Study.

Authors:  Leon M Ptaszek; Christopher W Baugh; Steven A Lubitz; Jeremy N Ruskin; Grace Ha; Margaux Forsch; Samer A DeOliveira; Samia Baig; E Kevin Heist; Jason H Wasfy; David F Brown; Paul D Biddinger; Ali S Raja; Benjamin Scirica; Benjamin A White; Moussa Mansour
Journal:  J Am Heart Assoc       Date:  2019-09-12       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.